Nursing care
Black Box Warnings, explained for the bedside and the exam
Written and reviewed by Dana Whitfield, RN, MSN · 4 min read · Updated September 2026
Short answer
A black box warning is the FDA's strongest label warning, reserved for drugs with a serious or life-threatening risk. Antidepressants carry one for increased suicidality in patients under 25, and fluoroquinolones carry one for tendon rupture. The nurse's job is knowing which drugs carry one and monitoring accordingly, not just noting that a warning exists.
The idea in one paragraph
A black box warning is a boxed section at the top of a drug's prescribing information, required by the FDA when a medication carries a risk of death or serious injury. It sits above the rest of the label deliberately, so it's the first thing a prescriber or pharmacist sees. It doesn't mean the drug is banned or even rarely used — many black box drugs, like SSRIs and fluoroquinolones, are prescribed constantly.
What it means practically is that the risk is well-documented enough that the FDA requires it to be impossible to miss. For nursing practice, that translates into specific monitoring and patient education obligations tied to that particular risk, not a general instruction to 'be careful.'
Why it matters clinically
Antidepressants, particularly SSRIs and SNRIs, carry a black box warning for increased suicidal thinking and behaviour in children, adolescents and young adults up to age 25, especially in the first weeks of treatment or after a dose change. This isn't a reason to withhold the drug — untreated depression carries its own serious risk — but it is a reason for closer monitoring in that age group during initiation.
Fluoroquinolones, including ciprofloxacin and levofloxacin, carry a black box warning for tendon rupture and tendinitis, with the Achilles tendon most often affected. Risk rises in patients over 60, those on corticosteroids, and organ transplant recipients. A nurse who doesn't know this warning exists won't ask about calf pain or connect a patient's sudden difficulty walking to the antibiotic they started three days ago.
How to apply it at the bedside
Know the black box warnings tied to the drug classes you administer most often, not every warning for every drug in the formulary. For antidepressants, that means screening for suicidal ideation at initiation and after dose changes, and educating patients and families to report worsening mood or new suicidal thoughts immediately, particularly in younger patients.
For fluoroquinolones, ask about tendon pain, swelling or weakness at each contact, and instruct patients to stop the drug and seek care if they notice these symptoms rather than pushing through a course. Cross-check other risk factors already on the chart, like concurrent corticosteroid use or a history of tendon disorders, since these compound the risk the warning describes.
Where students get it wrong
Students often treat 'black box warning' as a vague synonym for 'dangerous drug' rather than learning what the specific warning is for. Knowing that warfarin has one is useless without knowing it's about bleeding risk requiring INR monitoring, just as knowing metoclopramide has one is useless without knowing it's about tardive dyskinesia with prolonged use.
The second common error is assuming a black box warning means the drug should be avoided or that administering it requires special permission. It doesn't. It means informed, active monitoring for a known serious risk — the drug is still first-line therapy in many of these cases, and the correct nursing response is vigilance, not avoidance.
Worked examples
A 17-year-old starts sertraline for major depressive disorder. The nurse's role includes teaching the patient and a parent to watch for agitation, worsening mood or new suicidal thoughts in the first few weeks, and to contact the prescriber immediately if these appear, rather than waiting for a scheduled follow-up.
A 68-year-old on prednisone for a COPD flare is prescribed levofloxacin for a concurrent infection. The nurse should recognise the combination of age and corticosteroid use as compounding tendon rupture risk, ask specifically about calf or heel pain during the course, and report any new tendon symptoms rather than attributing them to deconditioning.
How the exam tests it
NCLEX questions test whether you can connect a drug name to its specific black box risk and select the matching nursing action — not whether you can recite the definition of a black box warning. Expect a scenario naming a drug class and asking which assessment finding should prompt the nurse to hold the drug or notify the provider.
A common distractor pattern presents a mild, expected side effect alongside the serious black-box-associated symptom, and asks you to identify which one requires urgent action. The exam rewards recognising the specific serious risk tied to that drug — suicidality for antidepressants, tendon rupture for fluoroquinolones — over generic caution.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our pharmacology practice questions are the closest set to what this page covers.
One question from the pharmacology set
A client with heart failure is started on furosemide 40 mg PO daily. Which findings should the nurse report to the provider before administering the next dose? Select all that apply.
Rationale
Furosemide is a loop diuretic, so the two things you are watching are potassium and kidney function. A potassium of 2.9 mEq/L is below the 3.5–5.0 reference range and puts the client at risk for dysrhythmia — hold and report. Muscle cramps with palpitations are the clinical face of that same hypokalemia, so they are reported together, not separately. A creatinine that doubles signals the diuresis has outrun renal perfusion. A blood pressure of 132/78 and a 1 kg loss are the expected response to the drug working, not reasons to hold it.
Answer: A, D, E
Common questions
Does a black box warning mean a drug can't be given to certain patients?
Not automatically. It means there's a documented serious risk requiring specific monitoring or caution in certain populations, but the drug often remains appropriate and is widely prescribed within those precautions.
Which drug classes commonly carry black box warnings that nurses should know?
Antidepressants for suicidality risk under 25, fluoroquinolones for tendon rupture, warfarin for bleeding risk, metoclopramide for tardive dyskinesia, and atypical antipsychotics for increased mortality in elderly patients with dementia are frequently tested examples.
Who decides when a drug gets a black box warning?
The FDA requires it based on post-marketing data or clinical trial evidence showing a serious or life-threatening risk. It can be added to a drug's label years after approval, once the risk becomes clear from wider use.
What should a nurse do if a patient develops a symptom matching a drug's black box warning?
Stop further administration if appropriate, document the finding, and notify the prescriber promptly rather than waiting for the next scheduled assessment. Early recognition is the point of the warning existing at all.
More on pharmacology
Guides on this